| Drug Type ASO | 
| Synonyms Antisense HIV-1 therapy, StealthVectorHGTV43 | 
| Target | 
| Action inhibitors | 
| Mechanism Tat (HIV) inhibitors(Human Immunodeficiency Virus tat Gene Products inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 2 | 
| First Approval Date- | 
| Regulation- | 

| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | - | - | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| HIV Infections | Phase 2 | United States  | 30 Jan 2022 | 





